Statistical Table 20: Prevalence of antibodies against hepatitis B virus among injecting drug users in the EU (sample sizes in brackets)
|
|
|
- Andrea Freeman
- 5 years ago
- Views:
Transcription
1 Belgium, French Community 23.5 ( ( ( (27 SR selfreported test results; > 80% missing data. Belgium, Flemish Community 7.9 ( ( ( (33 7. (3 AHBs. Drug, 2 Belgium, Flemish Community Belgium, Flemish Community - Antwerp 20.5 ( ( ( ( ( (250 AHBc. Drug Anti-HBs: Drug centres, low threshold services; 2 8
2 Belgium, Flemish Community -Antwerp 43.0 (249 AHBc: Drug centres, low threshold services, 8 Belgium, French Community - Charleroi 6.0 ( (238 All markers; general practitioners; 0
3 Denmark, Funen 68 (357 AHBc or HBsAg: prison, drug centres. Denmark, Copenhage n 64 (247 2
4 Germany, 36 (8 45 (7 52 (40 AHBc. Inpatient 4 Germany, 35 (8 42 (7 63 (40 AHBs. Inpatient 4 Germany, Hamburg 59.6 (6202 Prisons; 8 markers?
5 Greece, 0.2 (637 /SR centres, selfreported test results. Greece, National 58.0 ( (30 Prison; 0 Greece, Athens 8.6 (35 /SR Markers? Prisons; selfreported test results. Greece, Athens and Patras 67.2 (365 Prisons; 2
6 Spain, National excl. Galicia 59. (970 Survey drug 3 HBs Ag or ahbc positive.
7 France, 7.5 (775 SR Needle exchanges; selfreported test results. 3 France, Bordeaux Cayenne Dijon Fortde France Lille Lyon Marseille Paris Renne La Reunion Toulouse France, Toulouse 35.8 ( (30 SR SR Needle exchanges, low threshold services; selfreported test results. centers, low threshold service, prisons, arrests, GPs; self-reported test results. 45.9% unknown status. 4 4
8 France, Lille 42 (88 SR centers, low threshold service, prisons, arrests, GPs; self-reported test results. 56.7% unknown status. 4
9 Ireland, 8.5 (509 AHBc. Prison inmates; saliva; ever-idus 4 Ireland, National 7.9 (73 AHBc. Prison entrants; saliva; ever-idus 2 Ireland, Eastern Regional Health Authority 3.6 (36 Survey GPs: methadone clients, laboratory reports or clinical notes; 3.6% (78/57 non-idus, 45% (255/57 missing HBV status. 5
10 Ireland, Dublin 28. (64 ahbc; Five drug centres: methadone clients, laboratory reports or clinical notes; serum; may include non- IDUs. 6
11 43.8 ( Sardegna Sicilia Calabria Campania Lazio Marche Toscana Emilia Romagna Liguria Friuli Piemonte Puglia Piemonte Valle d Aosta 50.9 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (57 serum; 5-0% HbsAg or antihbc or antihbs. Drug sample study in 2 regions; data are for ; serum; 5-0% serum; 5-0% 3
12 Lombardia Trentino Trento 7.4 ( ( (48 8. ( ( ( ( ( ( ( ( ( ( ( ( (60 47 ( ( ( ( ( ( (368 serum; 5-0% serum; 5-0% serum; 5-0% Bolzano 66.5 ( ( ( ( ( ( ( ( ( ( (2 serum; 5-0% Veneto 49.2 ( ( ( ( ( (4452 serum; 5-0%
13 Friuli Friuli Liguria Liguria 54.3 ( ( ( ( ( ( ( ( ( ( ( ( ( (2755 serum; 5-0% HbsAg or antihbc or antihbs. Drug sample study in 2 regions; data are for ; serum; 5-0% HbsAg or antihbc or antihbs. Drug sample study in 2 regions; data are for ; 3 3
14 Emilia Romagna Emilia Romagna Toscana Toscana 47.5 ( ( ( ( ( ( ( ( ( ( ( ( ( (3697 serum; 5-0% HbsAg or antihbc or antihbs. Drug sample study in 2 regions; data are for ; serum; 5-0% HbsAg or antihbc or antihbs. Drug sample study in 2 regions; data are for ; 3 3
15 Umbria Marche Marche Lazio 25.2 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (376 serum; 5-0% serum; 5-0% HbsAg or antihbc or antihbs. Drug sample study in 2 regions; data are for ; serum; 5-0% 3
16 Lazio Abruzzo Molise Campania 32.2 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (8376 HbsAg or antihbc or antihbs. Drug sample study in 2 regions; data are for ; serum; 5-0% serum; 5-0% serum; 5-0% 3
17 Campania Puglia 37.3 ( ( ( ( ( ( (5670 HbsAg or antihbc or antihbs. Drug sample study in 2 regions; data are for ; serum; 5-0% 3 Basilicata Calabria 33.8 ( ( ( ( ( ( ( ( ( ( ( (68 serum; 5-0% serum; 5-0%
18 Calabria Sicilia Sicilia Sardegna 29.0 ( ( ( ( ( ( ( ( ( ( ( ( ( (875 HbsAg or antihbc or antihbs. Drug sample study in 2 regions; data are for ; serum; 5-0% HbsAg or antihbc or antihbs. Drug sample study in 2 regions; data are for ; serum; 5-0% 3 3
19 Sardegna 49.6 (683 HbsAg or antihbc or antihbs. Drug sample study in 2 regions; data are for ; 3
20 Luxembour g, 24. ( ( ( (337 SR, low threshold, hospitals and police. Selfreported test results., 3
21 Netherland s, Limburg Heerlen/ Maastricht Netherland s, The Hague Netherland s, Rotterdam 60.7 ( ( ( (99 AHBc: Drug 6, centres, needle exchanges, low threshold services and methadona post; AHBc: Drug 9 centres, needle exchanges, low threshold services; AHBc: Drug 7 centers, methadone post and street; saliva.
22 Austria, Vienna 54.4 ( ( ( ( ( (68 All markers: low threshold services; 3 Austria, Lower Austria 64.7 (68 45 (66 All markers: drug 4 Austria, Vorarlberg 50 (0 24 (33 22 (27 22 (4 48 (29 25 (32 48 (27 All markers: drug 2
23 Portugal, National Portugal, Lisbon Portugal, Lisbon Xabregas Portugal, Lisbon Taipas 28.5 ( ( ( (34 6 centers; markers n.a.; IDU status unknown prevalence may be too low. AHBc: Study 4 low-threshold services 998/99, IDU status unknown prevalence may be too low; 8 centers; markers n.a.; IDU status unknown prevalence may be too low. AHBs. Drug 7
24 Portugal, Lisbon Taipas 6.3 (32 AHBc. Drug 7 Portugal, Lisbon- Taipas 6.2 (307 Portugal, 39.2 (227 Portugal, Coimbra 40.9 ( ( (06 8 center; markers n.a.; IDU status unknown prevalence may be too low. AHBs: Drug 2 includes data from public health laboratory and pregnant IDUs; AHBc: Drug 2 includes data from public health laboratory and pregnant IDUs;
25 Portugal, Évora Portugal, Évora Portugal, Santarém Portugal, Santarém Portugal, Sintra 50.0 ( ( ( ( (9 AHBs: Drug AHBc: Drug AHBs: Drug AHBc: Drug AHBc. Drug
26 Portugal, Sintra (6 AHBs. Drug 7 Portugal, Setúbal 4.9 (358 center; markers n.a.; IDU status unknown prevalence may be too low. Data
27 Sweden, 57.6 (84 Study in nine Prisons; saliva. 5 Sweden, Stockholm 75.0 (93?? Setting? Markers? 2
28 UK, England and Wales UK, England and Wales excl. London UK, England and Wales excl. London 34.7 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (2448 AHBc: Drug centres, needle exchanges, low threshold services and primary care and outreach; saliva. AHBc: Drug centres, needle exchanges, low threshold services and primary care and outreach; saliva. AHBc: 3 Community surveys, prisons, current IDUs, saliva. UK, England 9.9 (805 AHBc: Prisons, ever IDUs, saliva. 4
29 UK, London UK, London 40.4 ( ( ( ( ( ( ( ( ( ( (55 AHBc: Drug centres, needle exchanges, low threshold services and primary care and outreach; saliva. AHBc: 3 Community surveys, prisons, current IDUs, saliva. UK, London 8.5 (200 AHBc: Community survey, female current IDUs;, saliva. 7 UK, 3.2 ( ( (4.5 (22.5 (22.5 (22.6 (24 IDUs undergoing a named HIV test; Laboratory reports of first positive HIVantibody test. 9
30 Notes. Sample size is the number of positive plus negative tests (total valid tests. Prevalence is number positive divided by total valid tests, excluding missing values. Prevalence from sample size under 50 is not reliable. 2. Self-reported test results for HBV may be unreliable. 3. Saliva tests for hepatitis B underestimate prevalence. If test sensitivity is known then figures can be adjusted upwards by dividing prevalence by test sensitivity. Figures have not been adjusted. 4. Having health problems is one selection criterion for admission to drug in some countries or cities (Greece, Portugal, Rome, due to long waiting lists or special programmes for infected IDUs, this may result in upward bias of prevalence. Prevalence from data should therefore be interpreted in combination with non- data. 5. Data sources with no information on injecting status were excluded as far as possible, as such prevalence can severely underestimate prevalence among injectors in the same source. Some such sources were however included if samples were large or they provided trends over time, in which case it is indicated that injecting status is unknown and prevalence among injectors may be underestimated. * See Box 6 OL: Data sources prevalence ( for details of the sources. **=diagnostic testing; =specific prevalence study; SR=prevalence study based on self-reported test results
Statistical Table 13: Prevalence of HIV infection (%) among injecting drug users under age 25, in the EU (sample sizes between brackets)
Statistical Table 3: Prevalence of HIV infection (%) among injecting drug users under, in the EU (sample sizes between brackets) HIV IDUs under Belgium, French Community 99 992 993 994 995 996 997 998
Statistical Table 17: Prevalence of hepatitis C infection among injecting drug users under age 25 in the EU (%) (sample sizes between brackets)
Belgium, French Community 99 992 993 994 995 996 997 998 999 2000 200 / 40.9 (22) 47.4 (38) 3.9 (38) 26.7 (5) SR centres; self-reported test results. > 80% missing data. Belgium, French Community - Charleroi
Statistical Table 19: Prevalence of current hepatitis B infection (% with HbsAg) among injecting drug users in the EU (sample sizes in brackets)
Belgium, French Community - Lantin 1991 199 1993 1994 1995 1996 1997 1998 1999 000 001 / 7.7 (668 3.8 (708 5.4 (576 Prison, serum, tests on demand, prisoners, IDU may be too low. 6 Belgium, Flemish Community
The Italian decision to mandate. children vaccinations. Fortunato D Ancona, MD Italian Ministry of Health
The Italian decision to mandate children vaccinations Fortunato D Ancona, MD Italian Ministry of Health The ASSET FINAL EVENT Share and move for mobilization and mutual learning at local, national and
PDTA: assistential and diagnostic-therapeutic paths
PDTA: assistential and diagnostic-therapeutic paths Salvatore Leone Amici Onlus, National Coalition of Associations for Patients suffering Chronic Diseases (CnAMC), Italy What is IBD? Crohn s disease and
Special Olympics Family Leadership and Support. Family Program Example Special Olympics Italy
Special Olympics Family Leadership and Support Family Program Example Special Olympics Italy Special Olympics vision The new strategic plan Families are asked to become COMMUNITY BUILDERS National Organizing
L USO DELLA RISORSA ALBUMINA LA PROSPETTIVA DEL CLINICO
AISF-SIMTI POSITION PAPER - L USO APPROPRIATO DELL ALBUMINA Roma, 29 marzo 2016 L USO DELLA RISORSA ALBUMINA LA PROSPETTIVA DEL CLINICO Mauro Bernardi Semeiotica Medica Dipartimento di Scienze Mediche
Marina Davoli Department of Epidemiology Lazio Region/Italian National Agency for Regional Health Services
Marina Davoli Department of Epidemiology Lazio Region/Italian National Agency for Regional Health Services Main objectives of the PNE include: comparative evaluation among healthcare providers; comparative
PAIN makes a difference
PAIN makes a difference 1 yester day. large problem small solutions 2 not just compassion. 3 opioid consumption 2006!0.35 National healthcare service per capita disbursement 4 opioid consumption 2007!0.67
INTRAVENOUS INJECTING DRUG USE.
Injecting drug users in Europe Towards an educational approach Lucas Wiessing European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon lucas.wiessing@ emcdda.org www.emcdda.org It has been
PrEPararsi alla PrEP: indagine sulla propensione dei medici di malattie infettive
UOC Infezioni emergenti e Centro di riferimento AIDS Dipartimento di Epidemiologia Istituto Nazionale per le Malattie Infettive L. Spallanzani - IRCCS, Rome, Italy Profilassi con antiretrovirali pre- e
Screening di Popolazione. del Cancro Colorettale. C. Hassan
Screening di Popolazione del Cancro Colorettale C. Hassan The Present 1. Organized screening program - Active invitation (less inequality) - Rapid coverage of the target population (2 yrs) - Quality Assurance
ITALY New Development, Trends and in-depth information on selected issues
Focal Point Logo 2006 NATIONAL REPORT (2005 data) TO THE EMCDDA by the Reitox National Focal Point ITALY New Development, Trends and in-depth information on selected issues REITOX !"$ % &"!"'$(" ) $"$$(
A standardization study of the Italian version of Frenchay Aphasia Screening Test in aphasic patients and control subjects
9 th European Congress of Speech and Language Therapy Palazzo dei Congressi & Palazzo degli Affari, Florence, Italy 8/9 May 2015 A standardization study of the Italian version of Frenchay Aphasia Screening
Priority actions of the different Regional Prevention Plans: common features and innovations
Priority actions of the different Regional Prevention Plans: common features and innovations Francesca Russo (1), Federica Michieletto (1), Annarosa Pettenò (1), Chiara Postiglione (2), Giuseppina Napoletano
CONCLUSIONS (Random Thoughts and Take Home Questions) gianluigi casadei
CONCLUSIONS (Random Thoughts and Take Home Questions) gianluigi casadei IL SOLE 24 ORE (September 4, 2012) Sustainability of health spending is a known issue for a long time The current crisis has dramatized
Aim of the project. costs/expenditure, output, productivity, health outcomes, 1 The main aim of this project is to provide a quantitative analysis on:
Aim of the project 1 The main aim of this project is to provide a quantitative analysis on: costs/expenditure, output, productivity, health outcomes, of the Italian health care system based on patient
An Italian survey on the attitudes in treating breakthrough cancer pain in hospice
Support Care Cancer (2011) 19:979 983 DOI 10.1007/s00520-010-0919-5 ORIGINAL ARTICLE An Italian survey on the attitudes in treating breakthrough cancer pain in hospice Sebastiano Mercadante & Patrizia
INCREASING VACCINATION IN CHILDREN. Susanna Esposito
INCREASING VACCINATION IN CHILDREN Susanna Esposito Pediatric Highly Intensive Care Unit, University of Milan, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico Milan, Italy DISCLOSURE OF INTEREST
BLUETONGUE IN ITALY: RISK ANALYSIS ON THE INTRODUCTION INTO FREE TERRITORIES OF VAC- CINATED ANIMALS FROM RE- STRICTED ZONES.
BLUETONGUE IN ITALY: RISK ANALYSIS ON THE INTRODUCTION INTO FREE TERRITORIES OF VAC- CINATED ANIMALS FROM RE- STRICTED ZONES. Bruxelles, 3 Dicembre 2002 INTRODUCTION...1 Italian strategy against bluetongue...
Italian Observatory on Healthcare Report 2014 Health status and quality of care in the Italian Regions
Italian Observatory on Healthcare Report 2014 Health status and quality of care in the Italian Regions Summary by Dr. Alessandro Solipaca e Dr. Marta Marino Osservasalute Report 2013 Summary Since 12 years,
ABRCAdaBRA:Opening the Way to Women with a BRCA Mutation in Italy. Ornella Campanella February 5, 2016
ABRCAdaBRA:Opening the Way to Women with a BRCA Mutation in Italy Ornella Campanella February 5, 2016 Who we are? Everythings was born on Facebook two years ago. Then we met in Pavia during the 4 Pavia
Highlight underserved groups for screening, prevention and treatment of viral hepatitis B and C in Europe LJUBLJANA, SLOVENIA March 2016
Viral Hepatitis Prevention Board Highlight underserved groups for screening, prevention and treatment of viral hepatitis B and C in Europe LJUBLJANA, SLOVENIA 10-11 March 2016 Objectives To define and
Update of the universal vaccination programme in Italy
Update of the universal vaccination programme in Italy Progress in the prevention and control of hepatitis B in Italy, 12 years after the implementation of universal vaccination. Duration of immunity and
EMCDDA DOCUMENTS ON IMPROVING COMPARABILITY - DRUG-RELATED INFECTIOUS DISEASES
EMCDDA DOCUMENTS ON IMPROVING COMPARABILITY - DRUG-RELATED INFECTIOUS DISEASES 1. Draft guidelines key indicator infections 2. Infection Indicator Map 3. Standard table 09-INFECTIONS-2000 EMCDDA / 2000
Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration
Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration Alexander Grabenhofer-Eggerth TDI expert meeting - Lisbon,
2nd International Expert Meeting on Gluten Sensitivity Munich, December 1st 2012
2nd International Expert Meeting on Gluten Sensitivity Munich, December 1st 2012 NON CELIAC GLUTEN SENSITIVITY IN ADULTS: CLINICAL AND SEROLOGICAL ASPECTS Umberto Volta Coeliac Disease and Malabsorption
Models of good practice in drug treatment in Europe. Project group
Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 Mary L. Yost 404-520-6652 , LLC 23 Ridge Rd. Beaufort, SC 20097 Copyright Pending 2017 All rights reserved,
ECDC and Spanish Ministry of Health workshop:
ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,
Temporal and regional trends of choking injuries in children in Italy,
Lorenzoni et al. Injury Epidemiology (2018) 5:30 https://doi.org/10.1186/s40621-018-0160-0 ORIGINAL CONTRIBUTION Open Access Temporal and regional trends of choking injuries in children in Italy, 2001
Strategies of drug users to avoid infection with hepatitis C
With financial support from the Drug Prevention and Information Programme of the European Union Strategies of drug users to avoid infection with hepatitis C Results from five European countries Dr. Heike
New trends in harm reduction in Europe: progress made challenges ahead
New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm
Weekly Influenza Surveillance Report. Week 11
Weekly Influenza Surveillance Report Week 11 Report produced: 22/03/2001 Influenza activity in Ireland For the week ending the 18/03/01, week 11, influenza activity has increased. Sentinel general practices
An Italian experience of training teachers* under the School Fruit and Vegetables Scheme
An Italian experience of training teachers* under the School Fruit and Vegetables Scheme Laura Gennaro Research Centre for Food and Nutrition (CREA-AN) laura.gennaro@crea.gov.it *Project funded by the
HPV, Cancer and the Vaccination Programme
HPV, Cancer and the Vaccination Programme Dr Brenda Corcoran Consultant in Public Health Medicine HSE National Immunisation Office What is HPV? Human papillomavirus Over 200 types identified Spread by
What s the seismic risk perception in Italy?
What s the seismic risk perception in Italy? Crescimbene Massimo 1, La Longa Federica 1, Camassi Romano 2, Pino Nicola Alessandro 3, Peruzza Laura 4 1 INGV, Via di Vigna Murata 65, 143, Rome, Italy 2 INGV,
Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers
HIV and migrants Julia del Amo has received research grants awarded to her institution from Companies BMS, Gilead, ViiV and epidemiology teaching fees from ViiV, Gilead and MSD Dr Julia del Amo National
Melanoma in the Italian Population and Regional Environmental Influences: A National Retrospective Survey on Hospitalization Records
Int. J. Environ. Res. Public Health 2015, 12, 9102-9118; doi:10.3390/ijerph120809102 OPEN ACCESS Article International Journal of Environmental Research and Public Health ISSN 1660-4601 www.mdpi.com/journal/ijerph
Trends in injecting drug use in Europe
Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information
The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint
The current status of PrEP in Europe Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint DISCLOSURES I have received a research grant from Gilead Sciences awarded to my institution
Focus on PD. Roberto Russo. Azienda Ospedaliera Policlinico di Bari
Focus on PD Roberto Russo Azienda Ospedaliera Policlinico di Bari Peritoneal Dialysis Access Our meta-analysis clearly demonstrates benefits for catheters with a straight intraperitoneal segment Kidney
Dept. of Region Health
Dept. of Region Health Department of Epidemiology Lazio Region Health Authority FINAL REPORT Implementation, follow-up and analysis of cohort studies on mortality among drug users in European Union member
Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.
European Comparative Alcohol Study Europe and Alcohol Policy Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.BO 220 FIN-00531
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
Esme Moniz Cook University of Hull Centre of Dementia Research and Practice Humber NHS FT 16 September 2014
Esme Moniz Cook University of Hull Centre of Dementia Research and Practice Humber NHS FT 16 September 2014 What is psychosocial intervention applied research INTERDEM: Psychosocial INTERvention DEMentia
Rhynchophorus ferrugineus in Europe survey results Nándor Pete
Food and Veterinary Office Rhynchophorus ferrugineus in Europe survey results Nándor Pete Topics General situation in the EU Specific situation of the Member States Interceptions Conclusions R. ferrugineus
Fourth Report Better data quality. Addendum BETTER DATA QUALITY. Italian Arthroplasty Registry Project. English version of Tables and Figures
ITALIAN ARTHROPLASTY REGISTRY PROJECT Fourth Report 2017 Italian Arthroplasty Registry Project Better data quality BETTER DATA QUALITY for FOR better BETTER PATIENT patient SAFETY safety Fourth Report
Weekly influenza surveillance overview
SURVEILLANCE REPORT Weekly influenza surveillance overview 7 February 2014 Main surveillance developments in week 5/2014 (27 January 2014 2 February 2014) This first page contains the main developments
Overview of drug-induced deaths in Europe - What does the data tell us?
Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug
EIP AHA Valencia 2016 Towards an Active and Healthy Ageing. Emilia-Romagna Region - Reference Site EIP-AHA
EIP AHA Valencia 2016 Towards an Active and Healthy Ageing Emilia-Romagna Region - Reference Site EIP-AHA A Regional Model to Predict Identify and Manage Multimorbidity and Frailty Mirca Barbolini Valencia
MONSUE. A European Multicentre Study on Suicidal Behaviour and Suicide Prevention. EU-Grant 2003/ MONSUE
MONSUE A European Multicentre Study on Suicidal Behaviour and Suicide Prevention EU-Grant 2003/791077-MONSUE Background In many European countries, suicidal behaviour constitutes a major public and mental
Behavioural indicators in men who have sex with men
Behavioural indicators in men who have sex with men Dr. Brenda Spencer, IUMSP, Lausanne 13 th HIV/AIDS Think Tank Meeting First presented by Prof. Jonathan Elford, City University London European Parliament,
Drug Consumption Rooms Worldwide
Drug Consumption Rooms Worldwide Eberhard Schatz Correlation Network International Network of Drug Consumption Rooms Introduction Overview of the current state of DCR s worldwide Presentation of the INDCR
PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information
PARALLELISM AND THE LEGITIMACY GAP 1 Appendix A Country Information PARALLELISM AND THE LEGITIMACY GAP 2 Table A.1 Sample size by country 2006 2008 2010 Austria 2405 2255 0 Belgium 1798 1760 1704 Bulgaria
Angelos Hatzakis. 10th Paris Hepatology Conference
Angelos Hatzakis Professor of Epidemiology and Preventive Medicine Faculty of Medicine National and Kapodistrian University of Athens Co-Chair, Hepatitis B and C Public Policy Association 10th Paris Hepatology
MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa
MENTAL HEALTH CARE OECD HCQI Expert meeting 17 th of May, 2013 Rie Fujisawa Mental health indicators Any hospital readmissions for patients with schizophrenia Same hospital readmissions for patients with
Table Of Content. The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...
Table Of Content The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Institut Pasteur... 6 Health Division... 6 Nphs Communicable Disease Surveillance
European Innovation Partnership on Active and Healthy Ageing
European Innovation Partnership on Active and Healthy Ageing Jorge PINTO ANTUNES Deputy Head of Unit Innovation for Health DG SANCO, European Commission The challenge of an ageing global population the
Deceased donation data in the UK. Paul Murphy National Clinical Lead for Organ Donation United Kingdom
Deceased donation data in the UK Paul Murphy National Clinical Lead for Organ Donation United Kingdom Deceased donation data in the UK And the story behind it Paul Murphy National Clinical Lead for Organ
A SYSTEMATIC REVIEW OF HEPATITIS B AND C TESTING IN THE COUNTRIES OF THE WHO EUROPEAN REGION
A SYSTEMATIC REVIEW OF HEPATITIS B AND C TESTING IN THE COUNTRIES OF THE WHO EUROPEAN REGION Jeffrey V. Lazarus* 1, Ida Sperle1, Jürgen K. Rockstroh2, Alexander Spina3, Lucas Wiessing4 1CHIP, Rigshospitalet,
Epidemiology of Legionnaires Disease in Europe Birgitta de Jong on behalf of ELDSNet ESGLI conference 22 September 2016
Epidemiology of Legionnaires Disease in Europe 2015 Birgitta de Jong on behalf of ELDSNet ESGLI conference 22 September 2016 ELDSNet annual data set Methods ECDC coordination Collection of disaggregate
Clinical Research. The impact of economic crisis on mental and physical health in Italy
103 The impact of economic crisis on mental and physical health in Italy M. Ruggeri; S. Tomassi Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Italy
Provided in Cooperation with: Institute for Social and Economic Research (ISER), University of Essex
econstor www.econstor.eu Der Open-Access-Publikationsserver der ZBW Leibniz-Informationszentrum Wirtschaft The Open Access Publication Server of the ZBW Leibniz Information Centre for Economics Rondinelli,
APPENDIX 6 EPIDEMOLOGY OF CORNELIA DE LANGE SYNDROME
APPENDIX 6 EPIDEMOLOGY OF CORNELIA DE LANGE SYNDROME Table 1. List of European registries contributing to the study: years of data, total number of births, prenatal diagnosis policy, followup of cases
The forgotten group: a new HIV outbreak amongst people who inject drugs. Patricia Anderson Lead CNS BBV Brownlee Centre
The forgotten group: a new HIV outbreak amongst people who inject drugs Patricia Anderson Lead CNS BBV Brownlee Centre No conflicts to declare Potted History 1981 Modern wave of drug misuse Glasgow soared
Engagement in language assessment / Regions of Europe
Summary table: Engagement in language / Regions of This table lists the statistically significant differences in the engagement in activities by the respondents from different s of : If the word or appears
508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender
An overview of suicide statistics This document summarises information about suicide deaths in New Zealand covering up to 13. It does not attempt to explain causes of suicidal behaviour or causes of changes
HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015
HIV/AIDS Think Tank meeting: EMCDDA report Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 European Drug Report 2015 Drop o Trends in seizures by substance from 2009 o Drug and related long-term
Monthly measles and rubella monitoring report
SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data
The HeartQol questionnaire. Reliability, validity and responsiveness?
The HeartQol questionnaire. Reliability, validity and responsiveness? Stefan Höfer, PhD, MSc Associate Professor Medical University Innsbruck The HeartQoL Story Data collection: 2000 2010 Presentations:
POSITION PAPER PALLIATIVE CARE, PEDIATRIC PALLIATIVE CARE AND PAIN THERAPY: HUMANIZATION OF CARE
POSITION PAPER 1 PALLIATIVE CARE, PEDIATRIC PALLIATIVE CARE AND PAIN THERAPY: HUMANIZATION OF CARE GROUP LEADER: Basilicata Region OTHER PARTNERS: Calabria; Campania; Lazio; Marche; Piemonte; Prov. Aut.
HIV in Prison Situation in Frankfurt am Main
HIV in Prison Situation in Frankfurt am Main European Project ROME-SEMINAR, May 14.-15., 2008 Horst Herkommer, Sella Oneko Praxis Psychosoziale Beratung Frankfurt am Main Germany General remark: Situation
Smokefree Policies in Europe: Are we there yet?
Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially
Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke
«L Europe de la santé au service des patients» 13-14 October 2008 - Institut Pasteur Paris Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke Simona Giampaoli National Centre of
Hepatitis B vaccine alone or with HBIG in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis.
Hepatitis B vaccine alone or with HBIG in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis. Vana Papaevangelou (Greece) National and Kapodistrian University of Athens Chang SemFNM
Promoting hepatitis B vaccination
Promoting hepatitis B vaccination Introduction Hepatitis B is a serious blood borne infection that can exacerbate hepatitis C infection, can cause serious liver damage and sometimes results in death. Hepatitis
The Seismic Risk Perception Questionnaire Crescimbene M. 1, La Longa F. 1, Camassi R. 1, Pino N.A. 1.
The Seismic Risk Perception Questionnaire Crescimbene M. 1, La Longa F. 1, Camassi R. 1, Pino N.A. 1 1 Istituto Nazionale di Geofisica e Vulcanologia, Rome, Italy (massimo.crescimbene@ingv.it, +390651860808)
Geographic and socio-economic variation of sodium and potassium intake in Italy. Results from the MINISAL-GIRCSI programme. For peer review only
Geographic and socio-economic variation of sodium and potassium intake in Italy. Results from the MINISAL-GIRCSI programme. Journal: Manuscript ID: bmjopen-0-00 Article Type: Research Date Submitted by
WCPT COUNTRY PROFILE December 2017 SWEDEN
WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of
Data and CRF management: P. Vaghi (Saronno), P. Calisi (Arenzano - GE), C. Chiavetta (Genova), Aristea SpA (Genova), Segno & Forma SpA (Milano).
Monaldi Arch Chest Dis 2007; 68: 193-198 ISYDE 2008 ISYDE-2008 Study presentation The Italian SurveY on cardiac rehabilitation: a snapshot of current cardiac rehabilitation programmes and provides in Italy
HIV Risk Behaviour in Irish Intravenous Drug Users
Abstract HIV Risk Behaviour in Irish Intravenous Drug Users A. Dorman, E. Keenan, C. Schuttler, J. Merry, J. J. O Connor The Drug Treatment Centre Board, Trinity Court, 30/31 Pearse Street, Dublin 2. The
Key issues for HIV testing and
Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics
The health economic landscape of cancer in Europe
1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor
WCPT COUNTRY PROFILE December 2017 HUNGARY
WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising
Screening for hepatitis B and C among migrants in the European Union
Screening for hepatitis B and C among migrants in the European Union Conference on Migrants and Health 12 th May 2016, Lisbon, Portugal Amena Ahmad Hamburg University of Applied Sciences Germany Email:
WCPT COUNTRY PROFILE December 2017 SERBIA
WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising
Weekly Influenza Surveillance Report
Weekly Influenza Surveillance Report NVRL Week 14 2003 Report produced: 10/04/2003 This report is produced in collaboration with the Departments of Public Health Summary Influenza activity remains at low
MESOTHELIOMA MORTALITY SURVEILLANCE IN ITALY
MESOTHELIOMA MORTALITY SURVEILLANCE IN ITALY Lucia Fazzo, Pietro Comba Dipartimento di Ambiente e Connessa Prevenzione Primaria. Istituto Superiore di Sanità, Rome Introduction The objective of the present
Table Of Content. European Surveillance of Sexually Transmitted Infections... 2 Summary... 3 Coordinator, Leader contact and partners...
Table Of Content European Surveillance of Sexually Transmitted Infections... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Department of Health and Children/ East Coast Area Health Board...
Project Meeting Prague
Project Meeting Prague IO1 Assessment 9.11.217 CHRISTINA PADBERG ON BEHALF OF FRANKFURT UAS Current Status Assessment matrix was fully evaluated Experts have been interviewed, Interviews were fully evaluated
PLACEMENT AND TREATMENT OF MENTALLY ILL OFFENDERS LEGISLATION AND PRACTICE IN EU-MEMBER STATES
Central Institute of Mental Health European Commission - Health & Consumer Protection Directorate-General PLACEMENT AND TREATMENT OF MENTALLY ILL OFFENDERS LEGISLATION AND PRACTICE IN EU-MEMBER STATES
Screening programmes for Hepatitis B/C in Europe
Programme STI, HIV/AIDS and viral hepatitis Screening programmes for Hepatitis B/C in Europe Mika Salminen, Ph.D. European Centre for Disease Prevention and Control Why might screening be needed for hepatitis